These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11944631)

  • 41. [Pathogenic molecular mechanisms in non-alcoholic steatohepatitis].
    Alvarez-Martínez HE; Montaño-Estrada LF; Hernández-Cruz P; Pérez-Campos E
    Rev Gastroenterol Mex; 2004; 69(3):176-83. PubMed ID: 15759791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C and nonalcoholic fatty liver disease.
    Ramesh S; Sanyal AJ
    Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Liver disease in obese patients].
    Giostra E; Huber O; Morel P; Hadengue A
    Rev Med Suisse; 2007 Sep; 3(123):1939-41. PubMed ID: 17918488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N; Borlak J
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
    Parekh S; Anania FA
    Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of green tea in nonalcoholic fatty liver disease.
    Masterjohn C; Bruno RS
    Nutr Rev; 2012 Jan; 70(1):41-56. PubMed ID: 22221215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic evaluation of nonalcoholic fatty liver disease.
    Adams LA; Talwalkar JA
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S34-8. PubMed ID: 16540765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X; Li Z
    Chin J Dig Dis; 2006; 7(1):7-11. PubMed ID: 16412031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Non-alcoholic fatty liver].
    Tagle Arrospide M
    Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The emerging problem of nonalcoholic steatohepatitis (NASH).
    Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
    Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonalcoholic fatty liver disease: current and potential therapies.
    Ibrahim MA; Kelleni M; Geddawy A
    Life Sci; 2013 Feb; 92(2):114-8. PubMed ID: 23159641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonalcoholic fatty liver disease: the concept and confusion.
    Sanal MG
    Minerva Gastroenterol Dietol; 2011 Dec; 57(4):419-26. PubMed ID: 22105730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 2012 clinical update for internists in adult nonalcoholic fatty liver disease.
    Younossi ZM; Venkatesan C
    Panminerva Med; 2012 Mar; 54(1):29-37. PubMed ID: 22278114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.
    Polyzos SA; Kountouras J; Zavos C; Deretzi G
    J Clin Gastroenterol; 2012 Apr; 46(4):272-84. PubMed ID: 22395062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.
    Clark JM; Diehl AM
    JAMA; 2003 Jun; 289(22):3000-4. PubMed ID: 12799409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.